LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 67.41 | 84.90 | 4903 | 8766 | 0.5593 | 0.8336 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 69.11 | 84.90 | 910 | 8988 | 0.1013 | 0.4228 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 69.11 | 84.90 | 5957 | 8988 | 0.6628 | 0.8814 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 69.11 | 84.90 | 4992 | 8988 | 0.5554 | 0.8326 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 69.11 | 84.90 | 5013 | 8988 | 0.5577 | 0.8337 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 70.81 | 84.90 | 945 | 9132 | 0.1035 | 0.4291 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 70.81 | 84.90 | 6135 | 9132 | 0.6718 | 0.8855 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 70.81 | 84.90 | 5082 | 9132 | 0.5565 | 0.8337 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 70.81 | 84.90 | 5119 | 9132 | 0.5606 | 0.8356 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 72.52 | 84.90 | 1020 | 9214 | 0.1107 | 0.4444 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 72.52 | 84.90 | 6377 | 9214 | 0.6921 | 0.8940 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 72.52 | 84.90 | 5142 | 9214 | 0.5580 | 0.8347 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 72.52 | 84.90 | 5164 | 9214 | 0.5604 | 0.8359 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 74.22 | 84.90 | 1042 | 9343 | 0.1115 | 0.4473 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 74.22 | 84.90 | 6454 | 9343 | 0.6908 | 0.8938 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 74.22 | 84.90 | 5182 | 9343 | 0.5546 | 0.8335 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 74.22 | 84.90 | 5227 | 9343 | 0.5594 | 0.8358 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 75.93 | 84.90 | 1078 | 8970 | 0.1202 | 0.4594 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 75.93 | 84.90 | 6752 | 8970 | 0.7527 | 0.9172 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 75.93 | 84.90 | 5190 | 8970 | 0.5786 | 0.8437 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 75.93 | 84.90 | 5238 | 8970 | 0.5839 | 0.8462 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 77.64 | 84.90 | 1194 | 9245 | 0.1291 | 0.4780 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 77.64 | 84.90 | 6940 | 9245 | 0.7506 | 0.9170 | MN20160318_Q02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 77.64 | 84.90 | 5186 | 9245 | 0.5609 | 0.8362 | MN20160318_Q02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 77.64 | 84.90 | 5317 | 9245 | 0.5751 | 0.8430 | MN20160318_Q02 | L04 |